Bottom line
FBIOX vs FBDIX: the short answer
FBIOX (Biotechnology Portfolio) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 35% of their top holdings (by weight) are shared.
FBIOX is cheaper at 0.62% vs 1.01% — a difference of $39 a year per $10,000 invested.
Over five years, FBDIX returned +5.0% a year vs +3.5% for FBIOX (reporting dates differ).
FBDIX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
FBIOX vs FBDIX side by side
| FBIOX | FBDIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Franklin Templeton |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.62% | 1.01% |
| Annual cost per $10k | $62 | $101 |
| 10-yr cost on $10k (prospectus) | $774 | $1,728 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +36.4% | +43.9% |
| 5-yr return (annualized) | +3.5% | +5.0% |
| 10-yr return (annualized) | +6.9% | +6.4% |
| Best quarter | +33.6% | +29.5% |
| Worst quarter | −28.4% | −24.5% |
| Net assets (fund) | $5.3B | $1.2B |
| Number of holdings | 215 | 126 |
| Portfolio turnover | 45% | 38% |
| Returns as of | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBIOX | FBDIX | Difference |
|---|---|---|---|
| 2025 | +36.4% | +52.3% | −15.9% |
| 2024 | +7.3% | +4.0% | +3.3% |
| 2023 | +10.1% | +18.4% | −8.3% |
| 2022 | −15.9% | −12.7% | −3.2% |
| 2021 | −12.4% | −17.7% | +5.3% |
| 2020 | +38.3% | +29.9% | +8.5% |
| 2019 | +36.0% | +34.8% | +1.1% |
| 2018 | −10.7% | −15.7% | +5.0% |
| 2017 | +27.9% | +18.8% | +9.1% |
| 2016 | −23.7% | −17.2% | −6.6% |
Source: Fund prospectus bar charts
Holdings overlap
10 of FBIOX's top 25 holdings also appear in FBDIX's top 25.
| Holding | FBIOX | FBDIX |
|---|---|---|
| Amgen Inc | 6.53% | 4.39% |
| Gilead Sciences Inc | 4.82% | 3.86% |
| Praxis Precision Medicines Inc. | 2.47% | 1.91% |
| Insmed Inc | 2.25% | 1.99% |
| Argenx Se | 2.25% | 3.62% |
| Ascendis Pharma A/s | 2.04% | 2.56% |
| Revolution Medicines Inc | 2.02% | 3.01% |
| Jazz Pharmaceuticals Plc | 1.84% | 5.66% |
| Tango Therapeutics Inc | 0.98% | 1.23% |
| Bridgebio Pharma Inc | 0.89% | 1.67% |
Source: SEC Form N-PORT
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FBDIX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FAQ
What is the difference between FBIOX and FBDIX?
Which is cheaper, FBIOX or FBDIX?
Should I own both FBIOX and FBDIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.